REFERENCES
1. Grunert SC, Sass JO. 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces. Orphanet J Rare Dis 2020;15:48.
2. Alfadhel M, Al Othaim A, Al Saif S, et al. Expanded newborn screening program in Saudi Arabia: incidence of screened disorders. J Paediatr Child Health 2017;53:585-91.
3. Santarelli F, Cassanello M, Enea A, et al. A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency. Ital J Pediatr 2013;39:33.
4. Thompson S, Hertzog A, Selvanathan A, et al. Treatment of HMG-CoA lyase deficiency-longitudinal data on clinical and nutritional management of 10 Australian cases. Nutrients 2023;15:531.
5. Pie J, Lopez-Vinas E, Puisac B, et al. Molecular genetics of HMG-CoA lyase deficiency. Mol Genet Metab 2007;92:198-209.
7. Huemer M, Muehl A, Wandl-Vergesslich K, Strobl W, Wanders RJ, Stoeckler-Ipsiroglu S. Stroke-like encephalopathy in an infant with 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. Eur J Pediatr 1998;157:743-6.
8. Stacey TE, de Sousa C, Tracey BM, et al. Dizygotic twins with 3-hydroxy-3-methylglutaric aciduria; unusual presentation, family studies and dietary management. Eur J Pediatr 1985;144:177-81.
9. Alfadhel M, Abadel B, Almaghthawi H, et al. HMG-CoA lyase deficiency: a retrospective study of 62 saudi patients. Front Genet 2022;13:880464.
10. Yalcinkaya C, Dincer A, Gunduz E, Ficicioglu C, Kocer N, Aydin A. MRI and MRS in HMG-CoA lyase deficiency. Pediatr Neurol 1999;20:375-80.
11. Sass JO, Fukao T, Mitchell GA. Inborn errors of ketone body metabolism and transport: an update for the clinic and for clinical laboratories. J Inborn Errors Metabolism Scr 2018;6:2326409818771101.
12. Bhattacharya K, Matar W, Tolun AA, et al. The use of sodium DL-3-hydroxybutyrate in severe acute neuro-metabolic compromise in patients with inherited ketone body synthetic disorders. Orphanet J Rare Dis 2020;15:53.
13. Dalkeith T, Ellaway C, Thompson S. The use of 3-hydroxybutyrate in patients with fat oxidation disorders. In 12th International Congress of Inborn Errors of Metabolism. Barcelona, Spain; 2013.
14. François B, Bachmann C, Schutgens RBH. Glucose metabolism in a child with 3-hydroxy-3-methylglutaryl-coenzyme a lyase deficiency. J Inherit Metab Dis 1981;4:163-4.
15. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 2015;17:405-24.
16. Chalmers RA, Lawson AM. Organic acids in man: analytical chemistry, biochemistry and diagnosis of the organic acidurias. Dordrecht: Springer; 2012. Available from: https://link.springer.com/book/10.1007/978-94-009-5778-7 [Last accessed on 16 Sep 2023].
17. Goodman SI, Markey SP. Diagnosis of organic acidemias by gas chromatography-mass spectrometry. Lab Res Methods Biol Med 1981;6:1-158.
18. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321-4.
19. Devanapalli B, Balasubramaniam S, Carpenter K. D, L-3-hydroxybutyrate treatment of HMG-CoA lyase deficiency in a patient. In 13th International Congress of Inborn Errors of Metabolism. Rio de Janeiro, Brazil; 2017.
20. Gautschi M, Weisstanner C, Slotboom J, Nava E, Zurcher T, Nuoffer JM. Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy. Pediatr Res 2015;77:91-8.
21. Habarou F, Bahi-Buisson N, Lebigot E, et al. Ketone bodies as a possible adjuvant to ketogenic diet in PDHc deficiency but not in GLUT1 deficiency. JIMD Rep 2018;38:53-9.
22. Van Hove JL, Grunewald S, Jaeken J, et al. D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet 2003;361:1433-5.
23. Van Rijt WJ, Heiner-Fokkema MR, du Marchie Sarvaas GJ, et al. Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD. Pediatrics 2014;134:e1224-8.
24. van Rijt WJ, Jager EA, Allersma DP, et al. Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency. Genet Med 2020;22:908-16.
25. Plecko B, Stoeckler-Ipsiroglu S, Schober E, et al. Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. Pediatr Res 2002;52:301-6.
26. Fischer T, Och U, Marquardt T. Long-term ketone body therapy of severe multiple acyl-CoA dehydrogenase deficiency: a case report. Nutrition 2019;60:122-8.
